Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Georgios Z. Rassidakis"'
Autor:
Amineh Ghaderi, Mohammad-Ali Okhovat, Jemina Lehto, Luigi De Petris, Ehsan Manouchehri Doulabi, Parviz Kokhaei, Wen Zhong, Georgios Z. Rassidakis, Elias Drakos, Ali Moshfegh, Johan Schultz, Thomas Olin, Anders Österborg, Håkan Mellstedt, Mohammad Hojjat-Farsangi
Publikováno v:
Pharmaceutics, Vol 15, Iss 4, p 1148 (2023)
The ROR1 receptor tyrosine kinase is expressed in embryonic tissues but is absent in normal adult tissues. ROR1 is of importance in oncogenesis and is overexpressed in several cancers, such as NSCLC. In this study, we evaluated ROR1 expression in NSC
Externí odkaz:
https://doaj.org/article/1287c54575b8479d88d0bd97b869a154
Autor:
Tom A. Mulder, Maria L. Andersson, Lucia Peña-Pérez, Kia Heimersson, Ioanna Xagoraris, Björn E. Wahlin, Robert Månsson, Lotta Hansson, Georgios Z. Rassidakis, Marzia Palma
Publikováno v:
HemaSphere, Vol 6, Pp 15-16 (2022)
Externí odkaz:
https://doaj.org/article/df75b3c76f7d4ab7b4da4c1155415b62
Autor:
Ioanna Xagoraris, Konstantina Stathopoulou, Stefanie Renken, Andreas Lundqvist, Francois Xavier Claret, Elias Drakos, Georgios Z. Rassidakis
Publikováno v:
HemaSphere, Vol 6, Pp 23-24 (2022)
Externí odkaz:
https://doaj.org/article/eea37894eb98469ea4486fe390631f19
Autor:
Ioanna Xagoraris, Konstantina Stathopoulou, Persa Xyderou, Marzia Palma, Elias Drakos, Theodoros P. Vassilakopoulos, Georgios Z. Rassidakis
Publikováno v:
HemaSphere, Vol 6, Pp 24-24 (2022)
Externí odkaz:
https://doaj.org/article/a13334dbb0fe42918cf470fe097582a2
Autor:
Theodoros P. Vassilakopoulos, Athanasios Liaskas, Giuliana Rizzuto, Argyrios Symeonidis, Marzia Palma, Maria K. Angelopoulou, Chara Giatra, Flora Kondopidou, Maria Dimou, Alberto Musseti, Ioanna Xagoraris, Marina Siakantaris, Evgenia Verigou, Fotios Panitsas, John Asimakopoulos, Maria Arapaki, Chrysovalantou Chatzidimitriou, Marina Belia, Sotirios Sachanas, Penelope Korkolopoulou, Antonello Cabras, Eleni Variamis, Panayiotis Panayiotidis, Maria Bakiri, Themistoklis Karmiris, Georgios Z. Rassidakis, Paolo Corradini, Gerassimos Pangalis, Simonetta Viviani
Publikováno v:
HemaSphere, Vol 6, Pp 53-53 (2022)
Externí odkaz:
https://doaj.org/article/9af2f4353535489f97c76a2d794893b2
Autor:
Sean G Rudd, Nikolaos Tsesmetzis, Kumar Sanjiv, Cynthia BJ Paulin, Lakshmi Sandhow, Juliane Kutzner, Ida Hed Myrberg, Sarah S Bunten, Hanna Axelsson, Si Min Zhang, Azita Rasti, Petri Mäkelä, Si'Ana A Coggins, Sijia Tao, Sharda Suman, Rui M Branca, Georgios Mermelekas, Elisée Wiita, Sun Lee, Julian Walfridsson, Raymond F Schinazi, Baek Kim, Janne Lehtiö, Georgios Z Rassidakis, Katja Pokrovskaja Tamm, Ulrika Warpman‐Berglund, Mats Heyman, Dan Grandér, Sören Lehmann, Thomas Lundbäck, Hong Qian, Jan‐Inge Henter, Torsten Schaller, Thomas Helleday, Nikolas Herold
Publikováno v:
EMBO Molecular Medicine, Vol 12, Iss 3, Pp n/a-n/a (2020)
Abstract The deoxycytidine analogue cytarabine (ara‐C) remains the backbone treatment of acute myeloid leukaemia (AML) as well as other haematological and lymphoid malignancies, but must be combined with other chemotherapeutics to achieve cure. Yet
Externí odkaz:
https://doaj.org/article/ee94cd1a0d794c99b66c9335300d2f1e
Autor:
Martin Jädersten, Ingrid Lilienthal, Nikolaos Tsesmetzis, Magda Lourda, Sofia Bengtzén, Anna Bohlin, Cornelia Arnroth, Tom Erkers, Brinton Seashore‐Ludlow, Géraldine Giraud, Giti S. Barkhordar, Sijia Tao, Linda Fogelstrand, Leonie Saft, Päivi Östling, Raymond F. Schinazi, Baek Kim, Torsten Schaller, Gunnar Juliusson, Stefan Deneberg, Sören Lehmann, Georgios Z. Rassidakis, Martin Höglund, Jan‐Inge Henter, Nikolas Herold
Publikováno v:
Journal of Internal Medicine. 292:925-940
Background Treatment of newly diagnosed acute myeloid leukaemia (AML) is based on combination chemotherapy with cytarabine (ara-C) and anthracyclines. Five-year overall survival is below 30%, which has partly been attributed to cytarabine resistance.
Autor:
Agata M. Wasik, Nikolas Herold, Birger Christensson, Elin Ljung, Arne Kolstad, Georgios Z. Rassidakis, Björn E. Wahlin, Mats Jerkeman, Birgitta Sander, Mattias Carlsten, Mohammad H. A. Morsy, Joana M. Rodrigues, Magali Merrien, Sara Ek
Publikováno v:
Virchows Archiv
SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase (dNTPase) that restricts viral replication in infected cells and limits the sensitivity to cytarabine by hydrolysing its active metabolite, as recently shown in acute myeloid leukemia. Cyta
Autor:
Amineh Ghaderi, Amir Hossein Daneshmanesh, Ali Moshfegh, Parviz Kokhaei, Jan Vågberg, Johan Schultz, Thomas Olin, Sara Harrysson, Karin E Smedby, Elias Drakos, Georgios Z. Rassidakis, Anders Österborg, Håkan Mellstedt, Mohammad Hojjat-Farsangi
Publikováno v:
Biomedicines, Vol 8, Iss 6, p 170 (2020)
The receptor tyrosine kinase ROR1 is absent in most normal adult tissues, but overexpressed in several malignancies. In this study, we explored clinical and functional inhibitory aspects of ROR1 in diffuse large B-cell lymphoma (DLBCL). ROR1 expressi
Externí odkaz:
https://doaj.org/article/d36a9e454ef446bc87fdc28c52d68ddd
Autor:
Magali, Merrien, Agata M, Wasik, Elin, Ljung, Mohammad H A, Morsy, Joana, de Matos Rodrigues, Mattias, Carlsten, Georgios Z, Rassidakis, Birger, Christensson, Arne, Kolstad, Mats, Jerkeman, Sara, Ek, Nikolas, Herold, Björn E, Wahlin, Birgitta, Sander
Publikováno v:
Virchows Archiv : an international journal of pathology. 480(3)
SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase (dNTPase) that restricts viral replication in infected cells and limits the sensitivity to cytarabine by hydrolysing its active metabolite, as recently shown in acute myeloid leukemia. Cyta